Live
- Mandal Level CM Cup Sports Concludes in Ija with Promising Talent and Enthusiastic Participation
- Harish Rao Slams Revanth Reddy: "More Talk, Less Action"
- Revolutionising Oil and Gas: Gaurav Kumar Sinha’s AI-Driven Innovations Transforming Efficiency and Profitability
- Vishal Jain to head AiDASH facility
- Congress Central Election Committee has finalised the names of around 20 candidates for the upcoming Delhi Assembly elections
- District Collector Adarsh ​​Surabhi has ordered to expedite the land acquisition process related to irrigation projects in the district
- Economics and Public policy gets new platform in Bengaluru
- Residents Demand Action After Accidents Highlight Poor Road Safety Measures
- Rahul Gandhi Visits Hathras Victim's Family, Slams BJP For Injustice
- Nitin Gadkari Admits India's Road Safety Crisis, Urges Change In Human Behavior And Infrastructure
US: Malaria medicine being administered
Malaria medicine 'Hydroxychloroquine' is being administered to 1,100 coronavirus patients in New York, President Donald Trump has said
New York: Malaria medicine 'Hydroxychloroquine' is being administered to 1,100 coronavirus patients in New York, President Donald Trump has said, exuding confidence that the drug, touted as a "game-changer" by him, might give some incredible results in the fight against the disease that has infected over 140,000 people in the country.
An inexpensive drug widely used since 1955 to treat malaria, Hydroxychloroquine is considered to have relatively harmless side effects.
It is being tested out on the COVID-19 patients in New York on an experimental basis, hoping that this will give a solution in the treatment against the novel coronavirus.
"Hydroxychloroquine is being administered to 1,100 patients, people in New York along with the Z-pack, which is azithromycin, and it is very early yet.
It started two days ago, but we will see what happens,' Trump told reporters at a White House news conference.
